International Biotechnology (LON:IBT) Insider Katherine Cornish-Bowden Buys 1,500 Shares

International Biotechnology (LON:IBT) insider Katherine Cornish-Bowden purchased 1,500 shares of the stock in a transaction on Tuesday, December 17th. The shares were purchased at an average price of GBX 713 ($9.06) per share, with a total value of £10,695 ($13,596.49).

International Biotechnology Trading Down 2.1 %

IBT opened at GBX 698 ($8.87) on Wednesday. International Biotechnology has a twelve month low of GBX 588 ($7.48) and a twelve month high of GBX 734 ($9.33). The company has a fifty day moving average of GBX 694.15 and a 200-day moving average of GBX 677.59. The stock has a market cap of £257.98 million, a PE ratio of 1,454.17 and a beta of 0.21. The company has a quick ratio of 0.32, a current ratio of 0.46 and a debt-to-equity ratio of 9.66.

International Biotechnology Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, January 24th. Shareholders of record on Thursday, December 19th will be issued a dividend of GBX 15.56 ($0.20) per share. This is an increase from International Biotechnology’s previous dividend of $14.50. This represents a yield of 2.21%. The ex-dividend date of this dividend is Thursday, December 19th. International Biotechnology’s dividend payout ratio (DPR) is presently 6,041.67%.

About International Biotechnology

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.